Charles J Ryan

10PUBLICATIONS
98CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 25, 2026
Carboplatin, Cabazitaxel, and Abiraterone in High-Volume Metastatic Castration-Sensitive Prostate Cancer: The CASCARA Phase II Study.

Emmanuel S Antonarakis, Qing Cao, Victoria Catharine

|Jan 26, 2026
Evolution of AR and Non-AR Alterations in ctDNA of Patients with Metastatic Prostate Cancer Treated in the Phase III Alliance A031201 Trial.

José C Valentín López, Chenxi Yu, Todd P Knutson

|Jan 28, 2025
Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting.

John R Lozada, Andrew Elliott, Mark G Evans

|May 01, 2023
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.

Justin Hwang, Xiaolei Shi, Andrew Elliott

|Nov 29, 2022
Acute effect of high-intensity interval aerobic exercise on serum myokine levels and resulting tumour-suppressive effect in trained patients with advanced prostate cancer.

Jin-Soo Kim, Dennis R Taaffe, Daniel A Galvão

|Feb 17, 2022
A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer.

Ivan de Kouchkovsky, Arpit Rao, Benedito A Carneiro

Pageof 2

Frequent Collaborators

4 joint publications

Emmanuel S Antonarakis

3 joint publications

Benedito A Carneiro

2 joint publications

Fred Saad

2 joint publications

John R Lozada